Mickron

Micron Biomedical is a clinical-stage life science company developing a proprietary dissolvable microarray (microneedle) technology for the needle-free delivery of vaccines and therapeutics. The company's platform aims to improve global health by simplifying administration, eliminating the need for cold chain storage, and increasing patient compliance through a painless, patch-based delivery method. Micron is currently advancing several programs, including a Measles-Rubella vaccine patch that has successfully completed Phase 1/2 trials and is moving into Phase 2 in infants. Supported by major organizations like the Bill & Melinda Gates Foundation and the CDC, the company is also developing patches for polio, rotavirus, and influenza to expand global access to life-saving treatments.